Bank Of New York Mellon Corp Champions Oncology, Inc. Transaction History

Bank Of New York Mellon Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$4.0 - $4.67 $123,100 - $143,719	30,775 New	30,775 $124 Million
Q4 2022 Feb 14, 2023	BUY	$3.75 - $7.69 $115,406 - $236,659	30,775 New	30,775 $138,000
Q3 2021 Nov 12, 2021	SELL	$9.11 - $10.96 $191,765 - $230,708	-21,050 Reduced 40.62%	30,775 $314,000
Q2 2021 Aug 11, 2021	SELL	$8.45 - $11.72 $138,782 - $192,489	-16,424 Reduced 24.06%	51,825 $532,000
Q1 2021 May 13, 2021	SELL	$10.61 - $13.75 $5,198 - $6,737	-490 Reduced 0.71%	68,249 $771,000
Q4 2020 Feb 09, 2021	SELL	$8.39 - $13.27 $6,326 - $10,005	-754 Reduced 1.09%	68,739 $741,000
Q2 2020 Aug 12, 2020	BUY	$6.65 - $9.84 $114,233 - $169,031	17,178 Added 32.84%	69,493 $664,000
Q1 2019 May 14, 2019	SELL	$7.89 - $12.23 $1,293 - $2,005	-164 Reduced 0.31%	52,315 $512,000
Q4 2018 Feb 11, 2019	BUY	$7.29 - $15.27 $382,571 - $801,354	52,479 New	52,479 $409,000

5.81M

3.3K

6.1K

Ticker CSBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,522,400
Market Cap $53.7M
Description
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.